Journal of Clinical Oncology

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

I Ismaela Anna Vascotto F Filippo Antonica (Ismaela Anna Vascotto, MD; Filippo Antonica, MD; Giandomenico Roviello, MD; Lorenzo Antonuzzo, MD; and Ugo De Giorgi, MD: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Department of Nuclear Medicine, Vito Fazzi Hospital, Lecce, Italy; Department of Health Sciences, University of Florence, Florence, Italy; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy; Department of Experimental Medicine, University of Salento, Vito Fazzi Hospital, Lecce, Italy) G Giandomenico Roviello L Lorenzo Antonuzzo (Azienda Ospedaliero Universitaria Careggi, Florence, Italy) U Ugo De Giorgi (Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 44, Issue 24
Published August 20, 2026
Pages 2358-2359
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (5)

I

Ismaela Anna Vascotto

F

Filippo Antonica

Ismaela Anna Vascotto, MD; Filippo Antonica, MD; Giandomenico Roviello, MD; Lorenzo Antonuzzo, MD; and Ugo De Giorgi, MD: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Department of Nuclear Medicine, Vito Fazzi Hospital, Lecce, Italy; Department of Health Sciences, University of Florence, Florence, Italy; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy; Department of Experimental Medicine, University of Salento, Vito Fazzi Hospital, Lecce, Italy

G

Giandomenico Roviello

L

Lorenzo Antonuzzo

Azienda Ospedaliero Universitaria Careggi, Florence, Italy

U

Ugo De Giorgi

Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy

Related Articles from this Journal

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001

Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model

Curtis A. Lachowiez, Joshua F. Zeidner et al. Aug 2026 10.1200/jco-26-01801